Conjunctivitis clinical trials

The registry lists 361 studies for Conjunctivitis across more than 10 countries. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-18.

Studies

Recruiting first, then most recently updated. Showing 50 of 361 — search for more.

• Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the EyeRecruitingNCT076349131 country
• Efficacy of Fusidic Acid 1% in the Treatment of Bacterial ConjunctivitisRecruitingNCT06911424Phase 31 country
• Efficacy and Safety Evaluation for the Treatment of Allergy Against MitesRecruitingNCT04435990Phase 31 country
• Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.RecruitingNCT04898283Phase 31 country
• Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic SubjectsNot yet recruitingNCT064592191 country
• Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure Chamber-a Randomized Placebo-controlled Double-blind StudyRecruitingNCT06778213Phase 41 country
• THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMICRecruitingNCT067719081 country
• Allogenic Plasma Aliquots in the Treatment of Ligneous ConjunctivitisEnrolling by invitationNCT04275232Phase 31 country
• Investigating Epstein-Barr Virus Associated ConjunctivitisEnrolling by invitationNCT066893971 country
• Evaluation of TL-925 for the Treatment of Allergic ConjunctivitisRecruitingNCT06686472Phase 21 country
• The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic ConjunctivitisEnrolling by invitationNCT05839938Not applicable1 country
• Treatment of Ligneous Conjunctivitis in Children With Plasminogen DeficiencyRecruitingNCT05404932Not applicable1 country
• A Study of TL-925 for the Treatment of Allergic ConjunctivitisRecruitingNCT06153342Phase 21 country
• Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab TreatmentRecruitingNCT042766231 country
• Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen ExtractNot yet recruitingNCT05641272Phase 2/31 country
• Sponsor Initiated Expanded Access Protocol, Intermediate-Size Patient PopulationAvailableNCT04586062
• Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/RhinoconjunctivitisNot yet recruitingNCT05400811Phase 31 country
• Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious KeratoconjunctivitisCompletedNCT05636228Phase 22 countries
• Ophthalmological Adverse Events of Tralokinumab in ADCompletedNCT056829761 country
• The Efficacy Of SCH1 In The Treatment Of Acute Infectious ConjunctivitisCompletedNCT05356793Phase 21 country
• The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to PlaceboCompletedNCT01471184Not applicable1 country
• Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy SubjectsCompletedNCT06363292Phase 11 country
• A Study Evaluating the Safety of the Nasal PumpTerminatedNCT06329687Phase 41 country
• Topical rVA576 for Treatment of Atopic KeratoconjunctivitisTerminatedNCT04037891Phase 1/22 countries
• A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic ConjunctivitisCompletedNCT03660878Phase 1/21 country
• Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass PollenCompletedNCT05540717Phase 36 countries
• A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure ChamberCompletedNCT03709121Phase 1/21 country
• Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisCompletedNCT05579730Phase 31 country
• ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic ConjunctivitisCompletedNCT03494504Phase 31 country
• A Study in Adults With Grass Pollen-induced RhinoconjunctivitisCompletedNCT04881461Phase 36 countries
• Zanzibar Arts for Children's Eyesight Pilot TrialCompletedNCT06469697Not applicable1 country
• The Effects of a Large Language Model on Clinical Questioning SkillsCompletedNCT06229379Not applicable1 country
• The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.CompletedNCT04207736Phase 31 country
• Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult ParticipantsCompletedNCT05430919Phase 21 country
• Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial ConjunctivitisCompletedNCT02432807Phase 31 country
• Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in AdultsCompletedNCT06616922Phase 24 countries
• A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)CompletedNCT00311844Phase 4
• A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy AdultsCompletedNCT05969236Phase 11 country
• Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.Active, not recruitingNCT05520086Phase 1/21 country
• A Study Of TL-925 For The Treatment of ACCompletedNCT06293820Phase 21 country
• Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic ManifestationsCompletedNCT038619101 country
• Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT05848128Phase 31 country
• Efficacy of Zinc Fortified Fermented Wheat FlourCompletedNCT06092515Not applicable1 country
• Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 PandemicCompletedNCT043746561 country
• Tolerability of Grazax in Patients With Hayfever in Real Life SettingsCompletedNCT01433510Phase 41 country
• CDL Validation StudyCompletedNCT054614691 country
• Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.CompletedNCT00769886Phase 31 country
• PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal AbnormalitiesCompletedNCT05823961Not applicable1 country
• PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye SymptomsCompletedNCT05807360Not applicable1 country
• A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis PatientsCompletedNCT06212973Phase 31 country